Trials / Completed
CompletedNCT05559281
Botulinum Toxin Injection in Reducing Lip Scar Following Cleft Lip Repair
Evaluation of Botulinum Toxin Injection in Reducing Lip Scar Following Cleft Lip Repair (Randomized Controlled Clinical Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 0 Minutes – 1 Year
- Healthy volunteers
- Not accepted
Summary
A cleft lip is a congenital defect resulting from failing to merge developmental processes in the Orofacial region. One of the most common complications surgeons fear after cleft lip repair is a hypertrophic scar. A cleft scar negatively affects a patient's appearance, psychology, and function. Several techniques have been proposed to improve lip scars such as steroid therapy, laser therapy, and silica gel. Despite such efforts, the results were still unsatisfactory. Botulinum Toxin injections may provide a more reliable method
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Botulinum | injection of Botulinum Toxin injection in lip muscles following cleft lip repair surgically. |
| PROCEDURE | Fisher technique | The cleft lip will be treated surgically using the Fisher technique only. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2022-09-29
- Last updated
- 2022-10-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05559281. Inclusion in this directory is not an endorsement.